Login to Your Account

Amgen, CDC Team to Fight Infection Concerns in Cancer

By Donna Young

Thursday, May 28, 2009
Antibiotic-resistant infections in cancer patients have become a growing concern over the past five years, with methicillin-resistant Staphylococcus aureus (MRSA) being the most common in those receiving chemotherapy, according to a new survey sponsored by Amgen Inc. and the Centers for Disease Control and Prevention (CDC), which have teamed in a three-year initiative to tackle the problem. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription